Brief: Aelis Farma: Completion Of Patient Randomization For Study With AEF0117 For Treatment Of Cannabis Addiction

Aelis Farma SA

09/01/2024 17:32

Jan 9 (Reuters) - Aelis Farma SA  AELIS.PA :
    * AELIS FARMA ANNOUNCES COMPLETION OF PATIENT RANDOMIZATION
FOR
PHASE 2B STUDY WITH AEF0117 FOR THE TREATMENT OF CANNABIS
ADDICTION
    * AS PLANNED, 333 PATIENTS HAVE BEEN RANDOMIZED AT END OF
DECEMBER
2023 ACROSS 11 CLINICAL CENTERS IN UNITED STATES
    * CONFIRMS ANNOUNCED AVAILABILITY OF FIRST RESULTS OF STUDY
FOR
END OF Q2 OF 2024

Source text for Eikon:  ID:nBwRt9gva 
Further company coverage:  AELIS.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))